Tavanta is a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs that bring clinically meaningful benefits to patients with serious or debilitating diseases.

The company has a balanced approach to discovery and product development advancing late-stage compounds with near-term commercial potential and synthesizing novel small molecules and peptides.

Our corporate headquarters are in King of Prussia, PA, with a research and early product development facility in Budapest, Hungary. Through these centers, the company is geographically well situated to resource experienced talent for research and development, and for commercialization.